Safeguarding Women from Chemical Abortion Act withdraws approval for mifepristone and establishes a federal tort for harm caused by chemical abortion.
The Safeguarding Women from Chemical Abortion Act withdraws approval for the drug mifepristone, used for terminating intrauterine pregnancy, under the Federal Food, Drug, and Cosmetic Act. It establishes a federal tort allowing individuals who suffer bodily injury or mental health harm from using mifepristone to sue the manufacturer for compensatory and punitive damages, as well as attorney's fees and costs. The act also considers mifepristone misbranded if it is labeled for use in terminating pregnancy. This legislation aims to address potential harms associated with chemical abortion drugs.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.